Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endocytosis Properties of GD2-Specific Antibodies in Tumor Cells.
Makarova AO, Titov MM, Kalinovsky DV, Kholodenko IV, Kibardin AV, Larin SS, Svirshchevskaya EV, Deyev SM, Kholodenko RV. Makarova AO, et al. Among authors: larin ss. Biochemistry (Mosc). 2025 Mar;90(3):424-435. doi: 10.1134/S0006297925600395. Biochemistry (Mosc). 2025. PMID: 40367084
Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives.
Tanas AS, Sigin VO, Kalinkin AI, Litviakov NV, Slonimskaya EM, Ibragimova MK, Ignatova EO, Simonova OA, Kuznetsova EB, Kekeeva TV, Larin SS, Poddubskaya EV, Trotsenko ID, Rudenko VV, Karandasheva KO, Petrova KD, Tsyganov MM, Deryusheva IV, Kazantseva PV, Doroshenko AV, Tarabanovskaya NA, Chesnokova GG, Sekacheva MI, Nemtsova MV, Izhevskaya VL, Kutsev SI, Zaletaev DV, Strelnikov VV. Tanas AS, et al. Among authors: larin ss. Epigenomics. 2019 May;11(6):605-617. doi: 10.2217/epi-2018-0213. Epub 2019 Feb 7. Epigenomics. 2019. PMID: 30729807 Free article.
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Kalinovsky DV, Kibardin AV, Kholodenko IV, Svirshchevskaya EV, Doronin II, Konovalova MV, Grechikhina MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: larin ss. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646. J Immunother Cancer. 2022. PMID: 35764367 Free PMC article.
Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics.
Lobas AA, Pyatnitskiy MA, Chernobrovkin AL, Ilina IY, Karpov DS, Solovyeva EM, Kuznetsova KG, Ivanov MV, Lyssuk EY, Kliuchnikova AA, Voronko OE, Larin SS, Zubarev RA, Gorshkov MV, Moshkovskii SA. Lobas AA, et al. Among authors: larin ss. J Proteome Res. 2018 May 4;17(5):1801-1811. doi: 10.1021/acs.jproteome.7b00841. Epub 2018 Apr 16. J Proteome Res. 2018. PMID: 29619825
51 results